Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells.
Identifieur interne : 002F50 ( Ncbi/Merge ); précédent : 002F49; suivant : 002F51Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells.
Auteurs : Nicholas D. Huntington [Australie] ; Sabrina Carpentier [France] ; Eric Vivier [France] ; Gabrielle T. Belz [Australie]Source :
- Current opinion in immunology [ 1879-0372 ] ; 2016.
Descripteurs français
- KwdFr :
- Animaux, Cellules tueuses naturelles (cytologie), Cellules tueuses naturelles (immunologie), Communication cellulaire (immunologie), Facteur de transcription GATA-3 (génétique), Facteur de transcription GATA-3 (immunologie), Facteurs de transcription Forkhead (génétique), Facteurs de transcription Forkhead (immunologie), Humains, Immunité acquise, Immunité innée, Interleukine-15 (génétique), Interleukine-15 (immunologie), Lymphocytes T CD8+ (cytologie), Lymphocytes T CD8+ (immunologie), Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires (génétique), Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires (immunologie), Muqueuse (cytologie), Muqueuse (immunologie), Protéines de liaison à l'ADN (génétique), Protéines de liaison à l'ADN (immunologie), Protéines proto-oncogènes c-bcl-6, Régulation de l'expression des gènes (immunologie), Sous-populations de lymphocytes T (cytologie), Sous-populations de lymphocytes T (immunologie), Transduction du signal.
- MESH :
- cytologie : Cellules tueuses naturelles, Lymphocytes T CD8+, Muqueuse, Sous-populations de lymphocytes T.
- génétique : Facteur de transcription GATA-3, Facteurs de transcription Forkhead, Interleukine-15, Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires, Protéines de liaison à l'ADN.
- immunologie : Cellules tueuses naturelles, Communication cellulaire, Facteur de transcription GATA-3, Facteurs de transcription Forkhead, Interleukine-15, Lymphocytes T CD8+, Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires, Muqueuse, Protéines de liaison à l'ADN, Régulation de l'expression des gènes, Sous-populations de lymphocytes T.
- Animaux, Humains, Immunité acquise, Immunité innée, Protéines proto-oncogènes c-bcl-6, Transduction du signal.
English descriptors
- KwdEn :
- Adaptive Immunity, Animals, CD8-Positive T-Lymphocytes (cytology), CD8-Positive T-Lymphocytes (immunology), Cell Communication (immunology), DNA-Binding Proteins (genetics), DNA-Binding Proteins (immunology), Forkhead Transcription Factors (genetics), Forkhead Transcription Factors (immunology), GATA3 Transcription Factor (genetics), GATA3 Transcription Factor (immunology), Gene Expression Regulation (immunology), Humans, Immunity, Innate, Interleukin-15 (genetics), Interleukin-15 (immunology), Killer Cells, Natural (cytology), Killer Cells, Natural (immunology), Mucous Membrane (cytology), Mucous Membrane (immunology), Nuclear Receptor Subfamily 1, Group F, Member 3 (genetics), Nuclear Receptor Subfamily 1, Group F, Member 3 (immunology), Proto-Oncogene Proteins c-bcl-6, Signal Transduction, T-Lymphocyte Subsets (cytology), T-Lymphocyte Subsets (immunology).
- MESH :
- chemical , genetics : DNA-Binding Proteins, Forkhead Transcription Factors, GATA3 Transcription Factor, Interleukin-15, Nuclear Receptor Subfamily 1, Group F, Member 3.
- cytology : CD8-Positive T-Lymphocytes, Killer Cells, Natural, Mucous Membrane, T-Lymphocyte Subsets.
- immunology : CD8-Positive T-Lymphocytes, Cell Communication, DNA-Binding Proteins, Forkhead Transcription Factors, GATA3 Transcription Factor, Gene Expression Regulation, Interleukin-15, Killer Cells, Natural, Mucous Membrane, Nuclear Receptor Subfamily 1, Group F, Member 3, T-Lymphocyte Subsets.
- Adaptive Immunity, Animals, Humans, Immunity, Innate, Proto-Oncogene Proteins c-bcl-6, Signal Transduction.
Abstract
Protection of epithelial and mucosal surfaces is required for survival. The recent discovery of a diverse array of innate lymphoid cells that lie immediately beneath these surfaces has unexpectedly uncovered an entire defense system distinct from the adaptive system essential to protect these barriers. This multilayered design provides a robust system through coupling of two highly complementary networks to ensure immune protection. Here, we discuss the similarities in the hardwiring and diversification of innate lymphoid cells and T cells during mammalian immune responses.
DOI: 10.1016/j.coi.2015.11.008
PubMed: 26736074
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002254
- to stream PubMed, to step Curation: 002228
- to stream PubMed, to step Checkpoint: 002228
Links to Exploration step
pubmed:26736074Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells.</title>
<author><name sortKey="Huntington, Nicholas D" sort="Huntington, Nicholas D" uniqKey="Huntington N" first="Nicholas D" last="Huntington">Nicholas D. Huntington</name>
<affiliation wicri:level="4"><nlm:affiliation>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010, Australia. Electronic address: huntington@wehi.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Carpentier, Sabrina" sort="Carpentier, Sabrina" uniqKey="Carpentier S" first="Sabrina" last="Carpentier">Sabrina Carpentier</name>
<affiliation wicri:level="1"><nlm:affiliation>MI-mAbs, Marseille 13288, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>MI-mAbs, Marseille 13288</wicri:regionArea>
<wicri:noRegion>13288</wicri:noRegion>
<placeName><settlement type="city">Marseille</settlement>
<region type="région" nuts="2">Provence-Alpes-Côte d'Azur</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vivier, Eric" sort="Vivier, Eric" uniqKey="Vivier E" first="Eric" last="Vivier">Eric Vivier</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre d'Immunologie de Marseille-Luminy, Aix-Marseille University UM2, Inserm, U1104, CNRS UMR7280, Marseille 13288, France; Immunologie, Hôpital de la Conception, Assistance Publique - Hôpitaux de Marseille, Marseille 13385, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre d'Immunologie de Marseille-Luminy, Aix-Marseille University UM2, Inserm, U1104, CNRS UMR7280, Marseille 13288, France; Immunologie, Hôpital de la Conception, Assistance Publique - Hôpitaux de Marseille, Marseille 13385</wicri:regionArea>
<wicri:noRegion>13385</wicri:noRegion>
<placeName><settlement type="city">Marseille</settlement>
<region type="région" nuts="2">Provence-Alpes-Côte d'Azur</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Belz, Gabrielle T" sort="Belz, Gabrielle T" uniqKey="Belz G" first="Gabrielle T" last="Belz">Gabrielle T. Belz</name>
<affiliation wicri:level="4"><nlm:affiliation>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010, Australia. Electronic address: belz@wehi.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26736074</idno>
<idno type="pmid">26736074</idno>
<idno type="doi">10.1016/j.coi.2015.11.008</idno>
<idno type="wicri:Area/PubMed/Corpus">002254</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002254</idno>
<idno type="wicri:Area/PubMed/Curation">002228</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002228</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002228</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002228</idno>
<idno type="wicri:Area/Ncbi/Merge">002F50</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells.</title>
<author><name sortKey="Huntington, Nicholas D" sort="Huntington, Nicholas D" uniqKey="Huntington N" first="Nicholas D" last="Huntington">Nicholas D. Huntington</name>
<affiliation wicri:level="4"><nlm:affiliation>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010, Australia. Electronic address: huntington@wehi.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Carpentier, Sabrina" sort="Carpentier, Sabrina" uniqKey="Carpentier S" first="Sabrina" last="Carpentier">Sabrina Carpentier</name>
<affiliation wicri:level="1"><nlm:affiliation>MI-mAbs, Marseille 13288, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>MI-mAbs, Marseille 13288</wicri:regionArea>
<wicri:noRegion>13288</wicri:noRegion>
<placeName><settlement type="city">Marseille</settlement>
<region type="région" nuts="2">Provence-Alpes-Côte d'Azur</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vivier, Eric" sort="Vivier, Eric" uniqKey="Vivier E" first="Eric" last="Vivier">Eric Vivier</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre d'Immunologie de Marseille-Luminy, Aix-Marseille University UM2, Inserm, U1104, CNRS UMR7280, Marseille 13288, France; Immunologie, Hôpital de la Conception, Assistance Publique - Hôpitaux de Marseille, Marseille 13385, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre d'Immunologie de Marseille-Luminy, Aix-Marseille University UM2, Inserm, U1104, CNRS UMR7280, Marseille 13288, France; Immunologie, Hôpital de la Conception, Assistance Publique - Hôpitaux de Marseille, Marseille 13385</wicri:regionArea>
<wicri:noRegion>13385</wicri:noRegion>
<placeName><settlement type="city">Marseille</settlement>
<region type="région" nuts="2">Provence-Alpes-Côte d'Azur</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Belz, Gabrielle T" sort="Belz, Gabrielle T" uniqKey="Belz G" first="Gabrielle T" last="Belz">Gabrielle T. Belz</name>
<affiliation wicri:level="4"><nlm:affiliation>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010, Australia. Electronic address: belz@wehi.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Current opinion in immunology</title>
<idno type="eISSN">1879-0372</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adaptive Immunity</term>
<term>Animals</term>
<term>CD8-Positive T-Lymphocytes (cytology)</term>
<term>CD8-Positive T-Lymphocytes (immunology)</term>
<term>Cell Communication (immunology)</term>
<term>DNA-Binding Proteins (genetics)</term>
<term>DNA-Binding Proteins (immunology)</term>
<term>Forkhead Transcription Factors (genetics)</term>
<term>Forkhead Transcription Factors (immunology)</term>
<term>GATA3 Transcription Factor (genetics)</term>
<term>GATA3 Transcription Factor (immunology)</term>
<term>Gene Expression Regulation (immunology)</term>
<term>Humans</term>
<term>Immunity, Innate</term>
<term>Interleukin-15 (genetics)</term>
<term>Interleukin-15 (immunology)</term>
<term>Killer Cells, Natural (cytology)</term>
<term>Killer Cells, Natural (immunology)</term>
<term>Mucous Membrane (cytology)</term>
<term>Mucous Membrane (immunology)</term>
<term>Nuclear Receptor Subfamily 1, Group F, Member 3 (genetics)</term>
<term>Nuclear Receptor Subfamily 1, Group F, Member 3 (immunology)</term>
<term>Proto-Oncogene Proteins c-bcl-6</term>
<term>Signal Transduction</term>
<term>T-Lymphocyte Subsets (cytology)</term>
<term>T-Lymphocyte Subsets (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Cellules tueuses naturelles (cytologie)</term>
<term>Cellules tueuses naturelles (immunologie)</term>
<term>Communication cellulaire (immunologie)</term>
<term>Facteur de transcription GATA-3 (génétique)</term>
<term>Facteur de transcription GATA-3 (immunologie)</term>
<term>Facteurs de transcription Forkhead (génétique)</term>
<term>Facteurs de transcription Forkhead (immunologie)</term>
<term>Humains</term>
<term>Immunité acquise</term>
<term>Immunité innée</term>
<term>Interleukine-15 (génétique)</term>
<term>Interleukine-15 (immunologie)</term>
<term>Lymphocytes T CD8+ (cytologie)</term>
<term>Lymphocytes T CD8+ (immunologie)</term>
<term>Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires (génétique)</term>
<term>Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires (immunologie)</term>
<term>Muqueuse (cytologie)</term>
<term>Muqueuse (immunologie)</term>
<term>Protéines de liaison à l'ADN (génétique)</term>
<term>Protéines de liaison à l'ADN (immunologie)</term>
<term>Protéines proto-oncogènes c-bcl-6</term>
<term>Régulation de l'expression des gènes (immunologie)</term>
<term>Sous-populations de lymphocytes T (cytologie)</term>
<term>Sous-populations de lymphocytes T (immunologie)</term>
<term>Transduction du signal</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>DNA-Binding Proteins</term>
<term>Forkhead Transcription Factors</term>
<term>GATA3 Transcription Factor</term>
<term>Interleukin-15</term>
<term>Nuclear Receptor Subfamily 1, Group F, Member 3</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Cellules tueuses naturelles</term>
<term>Lymphocytes T CD8+</term>
<term>Muqueuse</term>
<term>Sous-populations de lymphocytes T</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>CD8-Positive T-Lymphocytes</term>
<term>Killer Cells, Natural</term>
<term>Mucous Membrane</term>
<term>T-Lymphocyte Subsets</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Facteur de transcription GATA-3</term>
<term>Facteurs de transcription Forkhead</term>
<term>Interleukine-15</term>
<term>Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires</term>
<term>Protéines de liaison à l'ADN</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Cellules tueuses naturelles</term>
<term>Communication cellulaire</term>
<term>Facteur de transcription GATA-3</term>
<term>Facteurs de transcription Forkhead</term>
<term>Interleukine-15</term>
<term>Lymphocytes T CD8+</term>
<term>Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires</term>
<term>Muqueuse</term>
<term>Protéines de liaison à l'ADN</term>
<term>Régulation de l'expression des gènes</term>
<term>Sous-populations de lymphocytes T</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD8-Positive T-Lymphocytes</term>
<term>Cell Communication</term>
<term>DNA-Binding Proteins</term>
<term>Forkhead Transcription Factors</term>
<term>GATA3 Transcription Factor</term>
<term>Gene Expression Regulation</term>
<term>Interleukin-15</term>
<term>Killer Cells, Natural</term>
<term>Mucous Membrane</term>
<term>Nuclear Receptor Subfamily 1, Group F, Member 3</term>
<term>T-Lymphocyte Subsets</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adaptive Immunity</term>
<term>Animals</term>
<term>Humans</term>
<term>Immunity, Innate</term>
<term>Proto-Oncogene Proteins c-bcl-6</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Humains</term>
<term>Immunité acquise</term>
<term>Immunité innée</term>
<term>Protéines proto-oncogènes c-bcl-6</term>
<term>Transduction du signal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Protection of epithelial and mucosal surfaces is required for survival. The recent discovery of a diverse array of innate lymphoid cells that lie immediately beneath these surfaces has unexpectedly uncovered an entire defense system distinct from the adaptive system essential to protect these barriers. This multilayered design provides a robust system through coupling of two highly complementary networks to ensure immune protection. Here, we discuss the similarities in the hardwiring and diversification of innate lymphoid cells and T cells during mammalian immune responses.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26736074</PMID>
<DateCreated><Year>2016</Year>
<Month>01</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>10</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>01</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0372</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>38</Volume>
<PubDate><Year>2016</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Current opinion in immunology</Title>
<ISOAbbreviation>Curr. Opin. Immunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells.</ArticleTitle>
<Pagination><MedlinePgn>86-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.coi.2015.11.008</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0952-7915(15)00165-X</ELocationID>
<Abstract><AbstractText>Protection of epithelial and mucosal surfaces is required for survival. The recent discovery of a diverse array of innate lymphoid cells that lie immediately beneath these surfaces has unexpectedly uncovered an entire defense system distinct from the adaptive system essential to protect these barriers. This multilayered design provides a robust system through coupling of two highly complementary networks to ensure immune protection. Here, we discuss the similarities in the hardwiring and diversification of innate lymphoid cells and T cells during mammalian immune responses.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huntington</LastName>
<ForeName>Nicholas D</ForeName>
<Initials>ND</Initials>
<AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010, Australia. Electronic address: huntington@wehi.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carpentier</LastName>
<ForeName>Sabrina</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>MI-mAbs, Marseille 13288, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vivier</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Centre d'Immunologie de Marseille-Luminy, Aix-Marseille University UM2, Inserm, U1104, CNRS UMR7280, Marseille 13288, France; Immunologie, Hôpital de la Conception, Assistance Publique - Hôpitaux de Marseille, Marseille 13385, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Belz</LastName>
<ForeName>Gabrielle T</ForeName>
<Initials>GT</Initials>
<AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010, Australia. Electronic address: belz@wehi.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>12</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Curr Opin Immunol</MedlineTA>
<NlmUniqueID>8900118</NlmUniqueID>
<ISSNLinking>0952-7915</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C084103">BCL6 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C418974">FOXP3 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050990">GATA3 Transcription Factor</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C494749">GATA3 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C569274">IL15 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019409">Interleukin-15</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D057132">Nuclear Receptor Subfamily 1, Group F, Member 3</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051560">Proto-Oncogene Proteins c-bcl-6</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C539900">RORC protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D056704" MajorTopicYN="Y">Adaptive Immunity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050990" MajorTopicYN="N">GATA3 Transcription Factor</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019409" MajorTopicYN="N">Interleukin-15</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009092" MajorTopicYN="N">Mucous Membrane</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057132" MajorTopicYN="N">Nuclear Receptor Subfamily 1, Group F, Member 3</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051560" MajorTopicYN="N">Proto-Oncogene Proteins c-bcl-6</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>11</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>11</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26736074</ArticleId>
<ArticleId IdType="pii">S0952-7915(15)00165-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.coi.2015.11.008</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Australie</li>
<li>France</li>
</country>
<region><li>Provence-Alpes-Côte d'Azur</li>
<li>Victoria (État)</li>
</region>
<settlement><li>Marseille</li>
<li>Melbourne</li>
</settlement>
<orgName><li>Université de Melbourne</li>
</orgName>
</list>
<tree><country name="Australie"><region name="Victoria (État)"><name sortKey="Huntington, Nicholas D" sort="Huntington, Nicholas D" uniqKey="Huntington N" first="Nicholas D" last="Huntington">Nicholas D. Huntington</name>
</region>
<name sortKey="Belz, Gabrielle T" sort="Belz, Gabrielle T" uniqKey="Belz G" first="Gabrielle T" last="Belz">Gabrielle T. Belz</name>
</country>
<country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Carpentier, Sabrina" sort="Carpentier, Sabrina" uniqKey="Carpentier S" first="Sabrina" last="Carpentier">Sabrina Carpentier</name>
</region>
<name sortKey="Vivier, Eric" sort="Vivier, Eric" uniqKey="Vivier E" first="Eric" last="Vivier">Eric Vivier</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F50 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002F50 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:26736074 |texte= Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:26736074" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |